Achieve Life Sciences to Present at LD Micro Invitational XI Virtual Conference
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences,…
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences,…
KARACHI, PAKISTAN / ACCESSWIRE / June 2, 2021 / JS Bank has joined hands with…
Management to Present Wednesday, June 9th, 2021 EL CAJON, CA / ACCESSWIRE / June 2,…
VANCOUVER, BC / ACCESSWIRE / June 1, 2021 / Pascal Biosciences Inc. (“Pascal” or the…
HOUSTON, TX / ACCESSWIRE / June 2, 2021 / National Energy Services Reunited Corp. (“NESR”) (NASDAQ:NESR)(NASDAQ:NESRW),…
VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / NV Gold Corporation (TSXV:NVX)(OTCQB:NVGLF)(FSE:8NV) (“NV Gold”…
VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Pampa Metals Corp. (“Pampa Metals” or…
VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Ximen Mining Corp. (TSXV:XIM)(FRA:1XMA)(OTCQB:XXMMF) (the “Company”…
VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Marvel Discovery Corp. (TSXV:MARV)(FRA:O4T1)(OTC PINK:IMTFF)(“Marvel” or…
ProPhotonix Adds New Wavelengths to UVC LED Disinfection Systems Range 265nm, 275nm, 285nm and 310nm…
Acquisition Extends Kofax’s Leadership Position in the Capture Marketplace While Enhancing Its Intelligent Automation Platform…
Top London law firm Oracle Solicitors has chosen a Pay As You Go legal document…
Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12…
Seasoned investment expert in the life science sector with impressive track-record UTRECHT, The Netherlands, June…
Saint-Herblain (France), June 2, 2021 – Valneva SE (“Valneva” or “the Company”), a specialty vaccine…
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) — Cellectis S.A. held its Annual Shareholders’ General…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN…
Montrouge, France, June 2, 2021 DBV Technologies to Present at Upcoming Investor Conferences DBV Technologies…
Phase III JUNIPERA study met its primary endpoint, with Cosentyx® (secukinumab) showing significantly longer time…
– Data from PROLONG Phase 2a proof-of-concept study of ebopiprant (OBE022) for spontaneous preterm labor…